IL6 and COVID-19: Numerous clinical studies have also revealed that elevated amounts of IL-10 in the serum of COVID-19 patients, alone or with IL-6, IL-12 or IL-1RA, may accurately predict progression to more severe form of disease and increased mortality (46, 215, 229–234).